These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25561685)

  • 1. Allopurinol use and risk of non-fatal acute myocardial infarction.
    de Abajo FJ; Gil MJ; Rodríguez A; García-Poza P; Álvarez A; Bryant V; García-Rodríguez LA
    Heart; 2015 May; 101(9):679-85. PubMed ID: 25561685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Acute Myocardial Infarction Among New Users of Allopurinol According to Serum Urate Level: A Nested Case-Control Study.
    Rodríguez-Martín S; de Abajo FJ; Gil M; González-Bermejo D; Rodríguez-Miguel A; Barreira-Hernández D; Mazzucchelli R; García-Lledó A; García-Rodríguez LA
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.
    Singh JA; Ramachandaran R; Yu S; Curtis JR
    BMC Cardiovasc Disord; 2017 Mar; 17(1):76. PubMed ID: 28288564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indices of central and peripheral body fat: association with non-fatal acute myocardial infarction.
    Oliveira A; Rodríguez-Artalejo F; Severo M; Lopes C
    Int J Obes (Lond); 2010 Apr; 34(4):733-41. PubMed ID: 20065979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tea consumption, incidence and long-term prognosis of a first acute myocardial infarction--the SHEEP study.
    Pyshchyta G; Mukamal KJ; Ahnve S; Hallqvist J; Gémes K; Ahlbom A; Janszky I
    Clin Nutr; 2012 Apr; 31(2):267-72. PubMed ID: 22075136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.
    Stamp LK; Taylor WJ; Jones PB; Dockerty JL; Drake J; Frampton C; Dalbeth N
    Arthritis Rheum; 2012 Aug; 64(8):2529-36. PubMed ID: 22488501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum urate levels and gout flares: analysis from managed care data.
    Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
    J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.
    Zandman-Goddard G; Amital H; Shamrayevsky N; Raz R; Shalev V; Chodick G
    Rheumatology (Oxford); 2013 Jun; 52(6):1126-31. PubMed ID: 23392592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating hyperuricemia of gout: safety and efficacy of febuxostat and allopurinol in older versus younger subjects.
    Becker MA; MacDonald PA; Hunt B; Gunawardhana L
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1011-7. PubMed ID: 22132950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in event rates of first and recurrent, fatal and non-fatal acute myocardial infarction, and 28-day case fatality in the Northern Sweden MONICA area 1985-98.
    Messner T; Lundberg V; Boström S; Huhtasaari F; Wikström B
    Scand J Public Health Suppl; 2003; 61():51-9. PubMed ID: 14660248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.
    Solomon DH; Schneeweiss S; Glynn RJ; Kiyota Y; Levin R; Mogun H; Avorn J
    Circulation; 2004 May; 109(17):2068-73. PubMed ID: 15096449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S44-9. PubMed ID: 21654269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gout, allopurinol use, and heart failure outcomes.
    Thanassoulis G; Brophy JM; Richard H; Pilote L
    Arch Intern Med; 2010 Aug; 170(15):1358-64. PubMed ID: 20696962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.
    Stamp LK; Turner R; Khalilova IS; Zhang M; Drake J; Forbes LV; Kettle AJ
    Rheumatology (Oxford); 2014 Nov; 53(11):1958-65. PubMed ID: 24899662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and acute myocardial infarction among women and men: A case-control study in Italy.
    Bosetti C; Negri E; Tavani A; Santoro L; La Vecchia C
    Prev Med; 1999 Nov; 29(5):343-8. PubMed ID: 10564625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.
    Hatoum H; Khanna D; Lin SJ; Akhras KS; Shiozawa A; Khanna P
    Postgrad Med; 2014 Mar; 126(2):65-75. PubMed ID: 24685969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of acute myocardial infarction with sudden sensorineural hearing loss: a population-based case-control study.
    Keller JJ; Wu CS; Kang JH; Lin HC
    Audiol Neurootol; 2013; 18(1):3-8. PubMed ID: 22948477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).
    Holme I; Aastveit AH; Hammar N; Jungner I; Walldius G
    J Intern Med; 2009 Dec; 266(6):558-70. PubMed ID: 19563390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.